# Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

> **NCT00766545** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 1095 (actual)

## Conditions studied

- Cerebral Infarction

## Interventions

- **DRUG:** cilostazol
- **DRUG:** placebo of cilostazol

## Key facts

- **NCT ID:** NCT00766545
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-04
- **Primary completion:** 1997-03
- **Final completion:** 1997-03
- **Target enrollment:** 1095 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766545, "Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00766545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*